Evidence map›Paper›PMID 42071800›Full record

ArticleMedicine2026

Fear of progression subtypes and their influencing factors in patients with coronary heart disease: A cross-sectional study using latent profile analysis.

Kai Bai, Weidong Huang, Jundan Luo, Zhiwen Deng, Shule Liu, Meiyi Yang, Jianan Tian, Yongduo Ma

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kai BaiSchool of Nursing, Changchun University of Chinese Medicine, Changchun, Jilin, China.ORCID 0009-0008-3075-3771
Weidong Huang
Jundan Luo
Zhiwen Deng
Shule Liu
Meiyi Yang
Jianan Tian
Yongduo Ma

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study analyzed the current status of fear of progression (FoP) in patients with coronary heart disease (CHD) and its latent profile categories, and explored the influencing factors of these different categories. A convenience sampling method was used to select CHD patients who were hospitalized in a tertiary hospital in Changchun City from October 2024 to June 2025 as the survey subjects. The general information questionnaire, the Chinese version of the simplified Fear of Disease Progression Scale, the Family Care Index Scale, the Pain Digital Evaluation Scale, and the Social Support Rating Scale were used for investigation. The potential profiles of FoP in CHD patients were analyzed, and the influencing factors were explored using univariate analysis and multivariate logistic regression. A total of 400 subjects were included in the survey. FoP in CHD patients could be divided into 3 latent profile categories: "Low-Risk Fear Type" (36.56%), "High-Risk Fear Type" (32.68%), and "Severe Fear Type" (30.76%). The influencing factors included pain, family per capita monthly income, family care, and chronic complications (all P < .05). The level of FoP in CHD patients is high and heterogeneous. Medical staff should focus on patients with a high-risk of fear and severe fear, and provide targeted prevention and psychological nursing for FoP in CHD patients as soon as possible, according to the characteristics and influencing factors of the different categories.

Indexed as

Coronary DiseaseDisease ProgressionFearAgedChinaCross-Sectional StudiesFemaleHumansMaleMiddle AgedRisk FactorsSurveys and Questionnairescoronary heart diseasefear of progressioninfluencing factors analysispotential profile analysis

Identifiers

PMID42071800
PMCPMC13124363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.